Latest filing published 15 Oct 2026 for Travere Therapeutics, Inc., €11.6M. Read the official filing
Eric Dube appears in our data through filings on Travere Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 15 September 2026 to 15 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 15 October 2026 came the latest disclosure, a transaction for €11.6M in Travere Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations